DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Coles AJ, Twyman CL, Arnold DL et al.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Lancet 2012;
380: 1829-1839
We do not assume any responsibility for the contents of the web pages of other providers.